Earlier this afternoon, Mirum Pharmaceuticals, Inc. issued a press release reporting our fourth quarter and full year 2025 financial results. Copies of the press release and our SEC filings are ...

Palvella Therapeutics (NASDAQ:PVLA) said it reported positive top-line results from its phase III SELVA study evaluating QTORIN 3.9% rapamycin in hydrogel as a once-daily topical treatment for ...

Theresa S Betancourt and colleagues argue that implementation and systems strengthening are urgently needed to integrate mental health and psychosocial support interventions across health, education, ...